ESC Premium Access

The effect of elevated triglycerides and purified eicosapentaenoic acid ethyl ester (EPA) for cardiovascular risk reduction in the UK Biobank population

Congress Presentation

About the speaker

Doctor Dina Radenkovic

Guy's and St Thomas' NHS Foundation Trust, Greater London (United Kingdom of Great Britain & Northern Ireland)
0 follower

56 more presentations in this session

Tafolecimab, a novel potential long-acting PCSK9 monoclonal antibody: efficacy and safety in healthy and hypercholesterolemia subjects

Speaker: Professor Y. Huo (Beijing, CN)

Thumbnail

Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects

Speaker: Doctor C. Becker (Wuppertal, DE)

Thumbnail

Physiologically-based pharmacokinetic (PBPK) exploration of extrinsic factors influencing vericiguat pharmacokinetics

Speaker: Doctor S. Frechen (Leverkusen, DE)

Thumbnail

Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study

Speaker: Doctor C. Ballantyne (Houston, US)

Thumbnail

Adherence to high-intensity statin therapy after acute coronary syndrome and its impact on patient outcome

Speaker: Doctor P. Sulzgruber (Vienna, AT)

Thumbnail

Access the full session

Pharmacology and Pharmacotherapy ePosters

Speakers: Doctor D. Radenkovic, Professor Y. Huo, Doctor C. Becker, Doctor S. Frechen, Doctor C. Ballantyne...
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb